Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.

Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in hu...

Full description

Bibliographic Details
Main Authors: Pauline Chaste, Nathalie Clement, Oriane Mercati, Jean-Luc Guillaume, Richard Delorme, Hany Goubran Botros, Cécile Pagan, Samuel Périvier, Isabelle Scheid, Gudrun Nygren, Henrik Anckarsäter, Maria Rastam, Ola Ståhlberg, Carina Gillberg, Emilie Serrano, Nathalie Lemière, Jean Marie Launay, Marie Christine Mouren-Simeoni, Marion Leboyer, Christopher Gillberg, Ralf Jockers, Thomas Bourgeron
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-07-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20657642/pdf/?tool=EBI
_version_ 1818421496771510272
author Pauline Chaste
Nathalie Clement
Oriane Mercati
Jean-Luc Guillaume
Richard Delorme
Hany Goubran Botros
Cécile Pagan
Samuel Périvier
Isabelle Scheid
Gudrun Nygren
Henrik Anckarsäter
Maria Rastam
Ola Ståhlberg
Carina Gillberg
Emilie Serrano
Nathalie Lemière
Jean Marie Launay
Marie Christine Mouren-Simeoni
Marion Leboyer
Christopher Gillberg
Ralf Jockers
Thomas Bourgeron
author_facet Pauline Chaste
Nathalie Clement
Oriane Mercati
Jean-Luc Guillaume
Richard Delorme
Hany Goubran Botros
Cécile Pagan
Samuel Périvier
Isabelle Scheid
Gudrun Nygren
Henrik Anckarsäter
Maria Rastam
Ola Ståhlberg
Carina Gillberg
Emilie Serrano
Nathalie Lemière
Jean Marie Launay
Marie Christine Mouren-Simeoni
Marion Leboyer
Christopher Gillberg
Ralf Jockers
Thomas Bourgeron
author_sort Pauline Chaste
collection DOAJ
description Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, Delta502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.
first_indexed 2024-12-14T13:11:17Z
format Article
id doaj.art-db5bfbc334f143c8acb3c470126be6b5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T13:11:17Z
publishDate 2010-07-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-db5bfbc334f143c8acb3c470126be6b52022-12-21T23:00:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-07-0157e1149510.1371/journal.pone.0011495Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.Pauline ChasteNathalie ClementOriane MercatiJean-Luc GuillaumeRichard DelormeHany Goubran BotrosCécile PaganSamuel PérivierIsabelle ScheidGudrun NygrenHenrik AnckarsäterMaria RastamOla StåhlbergCarina GillbergEmilie SerranoNathalie LemièreJean Marie LaunayMarie Christine Mouren-SimeoniMarion LeboyerChristopher GillbergRalf JockersThomas BourgeronMelatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, Delta502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20657642/pdf/?tool=EBI
spellingShingle Pauline Chaste
Nathalie Clement
Oriane Mercati
Jean-Luc Guillaume
Richard Delorme
Hany Goubran Botros
Cécile Pagan
Samuel Périvier
Isabelle Scheid
Gudrun Nygren
Henrik Anckarsäter
Maria Rastam
Ola Ståhlberg
Carina Gillberg
Emilie Serrano
Nathalie Lemière
Jean Marie Launay
Marie Christine Mouren-Simeoni
Marion Leboyer
Christopher Gillberg
Ralf Jockers
Thomas Bourgeron
Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
PLoS ONE
title Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
title_full Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
title_fullStr Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
title_full_unstemmed Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
title_short Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population.
title_sort identification of pathway biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20657642/pdf/?tool=EBI
work_keys_str_mv AT paulinechaste identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT nathalieclement identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT orianemercati identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT jeanlucguillaume identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT richarddelorme identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT hanygoubranbotros identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT cecilepagan identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT samuelperivier identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT isabellescheid identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT gudrunnygren identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT henrikanckarsater identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT mariarastam identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT olastahlberg identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT carinagillberg identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT emilieserrano identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT nathalielemiere identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT jeanmarielaunay identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT mariechristinemourensimeoni identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT marionleboyer identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT christophergillberg identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT ralfjockers identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation
AT thomasbourgeron identificationofpathwaybiasedanddeleteriousmelatoninreceptormutantsinautismspectrumdisordersandinthegeneralpopulation